Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Micael Owald has worked on the following 7 EPO patent applications which have been published in the last five years:

EP13709227

FVIIA-STF COMPLEXES EXHIBITING EXOSITE-MEDIATED SUPER ACTIVITY

IPC classification:
A61K 38/48, C07K 14/705, C07K 14/745, C12N 9/64
Applicant:
Novo Nordisk Health Care AG
Agent:
Multiple attorneys, Novo Nordisk A/S
Status:
APPLICATION WITHDRAWN
EP13777046

COAGULATION FACTOR VII POLYPEPTIDES

IPC classification:
A61K 38/48, A61K 47/48, C12N 9/64
Applicant:
Novo Nordisk Health Care AG
Agent:
Micael Owald, Novo Nordisk A/S
Status:
APPLICATION WITHDRAWN
EP13776814

FACTOR VII CONJUGATES

IPC classification:
A61K 47/48, A61P 7/04, C12N 9/64, C12N 15/57
Applicant:
Novo Nordisk Health Care AG
Agent:
Micael Owald, Novo Nordisk A/S
Status:
EXAMINATION IN PROGRESS
EP15174742

PROCESS FOR PROTEIN PRODUCTION

IPC classification:
C12M 3/06, C12N 5/00, C12N 9/64
Applicant:
Novo Nordisk Health Care AG
Agent:
Micael Owald, Novo Nordisk A/S
Status:
EXAMINATION IN PROGRESS
EP14786841

COAGULATION FACTOR VII POLYPEPTIDES

IPC classification:
A61K 38/48, C12N 9/64
Applicant:
Novo Nordisk Health Care AG
Agent:
Micael Owald, Novo Nordisk A/S
Status:
EXAMINATION REQUESTED
EP11764561

PROCESS FOR PROTEIN PRODUCTION

IPC classification:
C12M 3/06, C12N 5/00, C12N 9/64
Applicant:
Novo Nordisk Health Care AG
Agent:
Amanda Louise Simons, J A Kemp
Agent:
Micael Owald, Novo Nordisk A/S
Status:
PATENT GRANTED
EP15705571

FACTOR VII CONJUGATES

IPC classification:
A61K 47/48, A61P 7/02
Applicant:
Novo Nordisk Health Care AG
Agent:
Witte, Weller & Partner Patentanwälte mbB
Agent:
Micael Owald, Novo Nordisk A/S
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature